The FDA has approved Auvelity as the first non-antipsychotic treatment for agitation in Alzheimer's disease, marking a major ...
Doctors and patients are gaining an edge in the fight against Alzheimer’s disease by catching early warning signs with new screening methods.
Cochrane review says amyloid-targeting Alzheimer's drugs are ineffective, but the Alzheimer's Association and drug makers ...
Early diagnoses of Alzheimer’s disease could let patients decide whether to try treatments that have helped in past clinical ...
Take a blood test now, even without symptoms, and learn if you could some day develop Alzheimer’s disease. Whether you should ...
As an internal medicine doctor, I used to care for Alzheimer’s patients. Now, at just 60 years old, I am one. My diagnosis is not the future most people hope for — but there is finally a generation of ...
Families with rare gene mutations that cause Alzheimer's in middle age are giving scientists a unique window on the disease, ...
Medical Microinstruments (MMI) today announced the completion of the first robotic-assisted procedure in its REMIND U.S. IDE ...
One of the company’s more closely watched research assets, BIIB080 is now heading to late-stage testing based on “the ...
A model estimated how long anti-amyloid drugs might extend independent living for Alzheimer's patients. Patients with low baseline impairment could gain 10-13 months of independence with treatment.
Dementia affects over 57 million people worldwide, a number expected to nearly double in the next 20 years. This permanent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results